Mauna Kea Technologies Takes Confocal Microscopy to the Tissues: An Interview with Sacha Loiseau
Originally a tool for biologists, confocal microscopy provides high resolution in vivo imaging of cellular and subcellular tissue structures in real time. As a clinical solution, the technology is meant to help bridge the gap between more imprecise macroscopic imaging technologies (such as MRI, CT, PET, high-resolution ultrasound, etc.) and microscopic techniques used in the clinical laboratory. Medtech Insight talks with Sacha Loiseau, PhD, president and CEO of Mauna Kea Technologies, a French medical device firm that recently launched its Cellvizio platform, an advanced confocal laser microscopy system with ultra-thin fiber optic microprobes.
by Anne Staylor
In the field of gastroenterology, correct assessment of the gastrointestinal mucosa is extremely important in the early detection and endoscopic diagnosis of digestive tract diseases. Using standard endoscopy, it is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul
Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
